Persistence of photosensitivity

Epilepsia
G F HardingP M Jeavons

Abstract

One hundred patients with photosensitive epilepsy were investigated as part of an ongoing follow-up study. Average duration of follow-up was 14 years; mean age at follow-up was 27 years. All patients were EEG investigated using a standard technique of intermittent photic stimulation (IPS). The presence of a photoparoxysmal response (PPR) or a degraded PPR indicated the presence of photosensitivity. Seventy-seven patients became seizure free. Of the untreated patients, photosensitivity disappeared in 14 patients but was present in 32 patients. Of the patients who were treated, 31 showed evidence of PPRs or degraded PPRs, but 23 patients no longer showed evidence of photosensitivity. Thirty-two mothers had 67 children during the follow-up period. Thirteen have so far proved to be sensitive to IPS in the laboratory and four have also had photosensitive seizures induced in the outside environment. Nine of the children have been found not to be photosensitive nor have they had seizures. This study suggests that photosensitivity persists in at least two thirds of patients with photosensitive epilepsy and that valproate is effective in controlling this photosensitivity.

References

Oct 25, 1975·Lancet·P M Jeavons
Aug 1, 1979·Electroencephalography and Clinical Neurophysiology·A J WilkinsG F Harding
Aug 1, 1992·Electroencephalography and Clinical Neurophysiology·S WaltzH Doose
Jan 1, 1992·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·J F PugliaM J Soso
Sep 1, 1986·Epilepsia·P M JeavonsG F Harding
Oct 23, 1982·Lancet·E Robert, P Guibaud
Jan 1, 1993·Electroencephalography and Clinical Neurophysiology·R P GregoryR T Merry
Dec 17, 1994·Lancet·C D FerrieC P Panayiotopoulos

❮ Previous
Next ❯

Citations

Nov 25, 2003·Pediatric Neurology·Lakshmi NagarajanWendy Rosemary Dimitroff
Nov 10, 1998·Seizure : the Journal of the British Epilepsy Association·K RadhakrishnanA Venugopal
May 2, 2002·Acta Neurologica Scandinavica·A VerrottiF Chiarelli
Mar 21, 1998·Nature Medicine·G F Harding
Jan 22, 2005·Epilepsia·Betül BaykanAyşen Gökyiğit
Oct 26, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A VerrottiF Chiarelli
Sep 16, 1999·Epilepsia·G F Harding, P F Harding
Oct 21, 1999·Epilepsia·G F Harding, F Fylan
Sep 9, 2005·Epilepsia·Robert S FisherUNKNOWN Epilepsy Foundation of America Working Group
Jan 24, 2007·Epilepsia·Mario BrinciottiMaria Pugliatti
Dec 14, 2011·Epilepsia·Udaya SeneviratneWendyl D'Souza
Jul 31, 2013·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Alberto VerrottiSergio Agostinelli
Mar 26, 2005·Current Opinion in Neurology·Jaime ParraFernando H Lopes da Silva
Oct 22, 2005·Acta Neurologica Scandinavica. Supplementum·E Hirsch
Jun 17, 2006·Acta Neurologica Scandinavica. Supplementum·A AldenkampA Covanis
Jan 18, 2005·Epilepsy & Behavior : E&B·Dorothée G Kasteleijn-Nolst Trenité
Oct 22, 2008·Applied Ergonomics·G F A Harding, P F Harding
Sep 22, 2006·Epilepsy Research·Salvatore GrossoPaolo Balestri
Sep 14, 2000·Seizure : the Journal of the British Epilepsy Association·A D YalçinH Forta
Jun 14, 2000·Seizure : the Journal of the British Epilepsy Association·R AppletonB Acomb
Mar 22, 2016·Expert Review of Neurotherapeutics·Katia LinPeter Wolf
Oct 21, 2016·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Udaya SeneviratneWendyl DʼSouza
Apr 6, 2011·Journal of Child Neurology·Jared R Brosch, Meredith R Golomb
Dec 21, 2004·Journal of Child Neurology·Alberto VerrottiFrancesco Chiarelli
Mar 6, 2008·Clinical EEG and Neuroscience·John R Hughes
Jan 7, 2004·Epilepsia·Athanasios CovanisArnold J Wilkins
May 4, 2018·The Neurologist·Yeşim Gülen AbanozÇiğdem Özkara
Jun 9, 1999·Annals of Neurology·S TobimatsuM Kato
Oct 18, 2005·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Shashi S Seshia, Lionel Carmant
Sep 19, 2019·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Jie BaiYong-Hong Liu
Jan 16, 2021·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Pirgit Meritam LarsenSándor Beniczky
Feb 6, 2021·Neurología : publicación oficial de la Sociedad Española de Neurología·O A MartinezR Ebner
Sep 27, 2020·Seizure : the Journal of the British Epilepsy Association·Chaturbhuj RathorePrayag Makwana

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
P Wolf, R Goosses
Epilepsia
D G Kasteleijn-Nolst TrenitéArnold Wilkins
Electroencephalography and Clinical Neurophysiology
Stephan WaltzH Doose
Electroencephalography and Clinical Neurophysiology
P Jayakar, K H Chiappa
Seizure : the Journal of the British Epilepsy Association
K AsoT Ohki
© 2021 Meta ULC. All rights reserved